Scholars Central

Research articlePublished 2007

Identification and characterization of impurity in olmesartan medoxomil bulk drug

Authors: S.G.Hiriyanna, K.Basavaiah, Hari N.Pati, Bijay K.Mishra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Olmesartan medoxomil is an angiotensin II antagonist and is used as antihypertensive agent. Impurity profiling of olmesartanmedoxomil drug substance by reverse phase HPLC reveals the presence of a potential impurity. It was isolated by preparative liquid chromatography(Prep LC) and structural characterization was done by NMR and FT-IR. Further characterization was done on the basis of fragmentation pattern of this impurity by LC-MS/MS using Electron Spray Ionization (ESI) source and triple quadrapole mass analyzer. This impurity is characterized as 5-methyl-2- oxo-[1,3]dioxo-4-ylmethyl-4-(1-methoxy-1-methyl-ethyl)-2-propyl-1-{4- [2’(1H-tetrazol-5-yl)phenyl] phenyl}methyl imidazole-5-carboxylate.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Analytical Chemistry: An Indian Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnalytical Chemistry: An Indian Journal
  • SubjectChemistry
  • BylineArticles whose byline prints “S.G.Hiriyanna”
  • BylineArticles whose byline prints “K.Basavaiah”
  • BylineArticles whose byline prints “Hari N.Pati”
  • BylineArticles whose byline prints “Bijay K.Mishra”